Butallylonal
Butallylonal

Butallylonal is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which made it useful in the treatment of insomnia and as a pre-anesthetic agent. Like other barbiturates, Butallylonal works by depressing the central nervous system.
Chemical Properties
Butallylonal is chemically classified as a barbiturate, which is a class of drugs derived from barbituric acid. The chemical structure of Butallylonal includes a pyrimidine ring, which is characteristic of barbiturates. The presence of various substituents on the ring structure influences its pharmacological activity.
Pharmacology
Butallylonal acts as a central nervous system depressant. It enhances the activity of the gamma-aminobutyric acid (GABA) neurotransmitter by binding to the GABA_A receptor, which increases the duration of chloride ion channel opening, leading to hyperpolarization of the neuron and decreased neuronal activity.
Mechanism of Action
The primary mechanism of action of Butallylonal is through potentiation of GABAergic transmission. By binding to the GABA_A receptor, Butallylonal increases the inhibitory effects of GABA, leading to sedation and hypnosis.
Clinical Uses
Historically, Butallylonal was used as a sedative and hypnotic for the treatment of insomnia and as a pre-anesthetic medication. However, due to the development of safer alternatives, its use has declined.
Side Effects
Common side effects of Butallylonal include drowsiness, dizziness, and ataxia. In higher doses, it can cause respiratory depression, hypotension, and coma.
History
Butallylonal was first synthesized in the early 20th century as part of the development of barbiturate drugs. It was used clinically for several decades before being largely replaced by benzodiazepines and other non-barbiturate sedatives.
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian